Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1997-12-19
2000-05-23
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
514535, 514570, 514617, 514618, 514621, 514913, A61K 31165
Patent
active
060666714
ABSTRACT:
Compositions of 3-benzoylphenylacetic acid derivatives for treating GLC1A glaucoma and methods for their use are disclosed.
REFERENCES:
patent: 5475034 (1995-12-01), Yanni et al.
patent: 5606043 (1997-02-01), Nguyen et al.
"Mapping of a Gene for Autosomal Dominant Juvenile-Onset Open-Angle Glaucoma to Chromosome Iq", Richards, et al., American Journal of Human Genetics, vol. 54, Jan. 1, 1994, pp. 62-70.
"Fine Mapping of the Autosomal Dominant Juvenile Open Angle Glaucoma (CLC1A) Region and Evaluation of Candidate Genes", Sunden et al., Genome Research, vol. 6, No. 9, Sep. 1996, pp. 862-869.
"Cellular Pharmacology and Molecular Biology of the Trabecular Meshwork Inducible Glucocorticoid Response Gene Product", Polansky et al., Ophthalmologica, vol. 211, No. 3, May 1997, pp. 126-139.
"In Vitro Correlates of Glucocorticoid Effects on Intraocular Pressure", Polansky et al, Glaucoma Update, Jan. 1991, pp. 20-29.
Sommer A, et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. Arch. Ophthalmol. 109:1090-1095, (1991).
Sheffield, et al., "Genetic Linkage of Familial Open Angle Glaucoma to Chromosome 1q21-q31," Nature Genetics, 4:47-50 (1993).
Sarfarazi, et al., "Assignment of a Locus (GLC3A) for Primary Congenital Glaucoma (Buphthalmos) to 2p21 and Evidence for Genetic Heterogeneity," Genomics, 30:171-177 (1995).
Akarsu, et al., "A Second Locus (GLC3B) for Primary Congenital Glaucoma (Buphthalmos) Maps to the 1p36 Region," Human Molecular Genetics, 5(8): 1199-1203 (1996).
Stoilova, et al., "Localization of a Locus (GLC1B) for Adult-Onset Primary Open Angle Glaucoma to the 2cen-q13 Region," Genomics, 36:142-150 (1996).
Wirtz, et al., "Mapping a Gene for Adult-Onset Primary Open-Angle Glaucoma to Chromosome 3q," Am. J. Hum. Genet., 60:296-304 (1997).
Andersen, et al., "A Gene Responsible for the Pigment Dispersion Syndrome Maps to Chromosome 7q35-q36," Arch. Ophthalmol., 115:384-388 (1997).
Richards, et al., "Mapping of a Gene for Autosomal Dominant Juvenile-Onset Open-Angle Glaucoma to Chromosome 1q," Am. J. Hum. Genet., 54:62-70 (1994).
Morissette, et al., "A Common Gene for Juvenile and Adult-Onset Primary Open-Angle Glaucomas Confined on Chromosome 1q," Am. J. Hum. Genet., 56:1431-1442 (1995).
Wiggs, et al., "Genetic Linkage of Autosomal Dominant Juvenile Glaucoma to 1q21-q31 in Three Affected Pedigrees," Genomics, 21:299-303 (1994).
Meyer, et al., "Age-Dependent Penetrance and Mapping of the Locus for Juvenile and Early-Onset Open-Angle Glaucoma on Chromosome 1q (GLC1A) in a French Family," Hum. Genet., 98:567-571 (1996).
Graff, et al., "Confirmation of Linkage to 1q21-31 in a Danish Autosomal Dominant Juvenile-Onset Glaucoma Family and Evidence of Genetic Heterogeneity," Hum. Genet., 96:285-289 (1995).
Stone, et al., "Identification of a Gene That Causes Primary Open Angle Glaucoma," Science, 275:668-670 (1997).
Polansky, et al., "In Vitro Correlates of Glucocorticoid Effects on Intraocular Pressure," Glaucoma Update IV (1991).
Polansky, et al., "Cellular Pharmacology and Molecular Biology of the Trabecular Meshwork Inducible Glucocorticoid Response Gene Product," Ophthalmologica, 211:126-139 (1997).
Ortego, et al., "Cloning and Characterization of Subtracted cDNAs from a Human Ciliary Body Library Encoding TIGR, a Protein Involved in Juvenile Open Angle Glaucoma with Homology to Myosin and Olfactomedin," FEBS Letters, 413:349-353 (1997).
(Kubota, et al., "A Novel Myosin-like Protein (Myocilin) Expressed in the Connecting Cilium of the Photoreceptor: Molecular Cloning, Tissue Expression, and Chromosomal Mapping," Genomics, 41:360-369 (1997).
Sunden, et al., "Fine Mapping of the Autosomal Dominant Juvenile Open Angle Glaucoma (GLC1A) Region and Evaluation of Candidate Genes," Genome Research, 6:862-869 (1996).
Adam, et al., "Recurrent Mutations in a Single Exon Encoding the Evolutionarily Conserved Olfactomedin-Homology Domain of TIGR in Familial Open-Angle Glaucoma," Human Molecular Genetics, 6(12):2091-2097 (1997).
Rozsival, et al., "Aqueous Humour and Plasma Cortisol Levels in Glaucoma and Cataract Patients," Current Eye Research, 1:391-396 (1981).
Schwartz, et al., "Increased Plasma Free Cortisol in Ocular Hypertension and Open Angle Glaucoma," Arch. Ophthalmol., 105:1060-1065 (1987).
Wilson, et al., Dexamethasone Induced Ultrastructural Changes in Cultured Human Trabecular Meshwork Cells, Cur. Eye Res., 12:783-793 (1993).
Clark, et al., "Glucocorticoid-Induced Formation of Cross-Linked Actin Networks in Cultured Human Trabecular Meshwork Cells," Invest. Ophthalmol. Vis. Sci., 35:281-294 (1994).
Hellberg Mark R.
Yanni John M.
Alcon Laboratories Inc.
Fay Zohreh
Yeager Sally
LandOfFree
Treatment of GLC1A glaucoma with 3-benzoyl-phenylacetic acids, e does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of GLC1A glaucoma with 3-benzoyl-phenylacetic acids, e, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of GLC1A glaucoma with 3-benzoyl-phenylacetic acids, e will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1837464